Statement of Ownership (sc 13g)
October 15 2021 - 1:44PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. )*
Orion
Biotech Opportunities Corp.
(Name
of Issuer)
Class
A ordinary shares, $0.0001 par value per share, included as part of the Units
(Title
of Class of Securities)
G6780C125**
(CUSIP
Number)
May
14, 2021
(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
*
|
The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover
page
|
|
**
|
The
CUSIP provided is for units that consist of one Class A Ordinary Share, $0.0001 par value, and one-fifth of one redeemable warrant
|
The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that
section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
Name,
Address and Telephone Number of Person Authorized to Receive Notices and Communications:
Amy
Bowler
Holland
& Hart LLP
555
17th Street, Suite 3200
Denver,
Colorado 80202
(303)
295-8000
CUSIP
No. G6780C125
1
|
Names
of Reporting Person.
Gerald
D. Hosier
|
2
|
Check
the Appropriate Box if a Member of a Group
(a) ☐
(b) ☒
|
3
|
SEC
Use Only
|
4
|
Citizenship
or Place of Organization
|
|
|
|
USA
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5
|
Sole
Voting Power
1,500,000
(1)
|
6
|
Shared
Voting Power (see Item 5 below)
0
|
7
|
Sole
Dispositive Power
1,500,000
(1)
|
8
|
Shared
Dispositive Power (see Item 5 below)
0
|
9
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
1,500,000
|
10
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares
☐
|
11
|
Percent
of Class Represented by Amount in Row (11)
7.5%
(2)
|
12
|
Type
of Reporting Person
IN
|
|
(1)
|
Represents
1,500,000 Ordinary Shares (as defined herein) held by the Gerald D. Hosier Revocable Trust. Mr. Hosier, the trustee of the Gerald D.
Hosier Revocable Trust, has sole and dispositive power over the Ordinary Shares held by the Gerald D. Hosier Revocable Trust.
|
|
(2)
|
Based
on a total of 20,000,000 Ordinary Shares issued and outstanding as of August 12, 2021 as reported by the Issuer in its Quarterly Report
on Form 10-Q for the quarter ended June 30, 2021, filed by the Issuer with the SEC on August 12, 2021.
|
CUSIP
No. G6780C125
1
|
Names
of Reporting Person.
Gerald
D. Hosier Revocable Trust
|
2
|
Check
the Appropriate Box if a Member of a Group
(a) ☐
(b) ☒
|
3
|
SEC
Use Only
|
4
|
Citizenship
or Place of Organization
|
|
|
|
State
of Nevada
|
Number
of
Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5
|
Sole
Voting Power
1,500.000
(1)
|
6
|
Shared
Voting Power (see Item 5 below)
0
|
7
|
Sole
Dispositive Power
1,500.000
(1)
|
8
|
Shared
Dispositive Power (see Item 5 below)
0
|
9
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
1,500,000
|
10
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares
☐
|
11
|
Percent
of Class Represented by Amount in Row (11)
7.5%
(2)
|
12
|
Type
of Reporting Person
OO
|
|
(1)
|
Represents
1,500,000 Ordinary Shares held by the Gerald D. Hosier Revocable Trust. Mr. Hosier, the trustee of the Gerald D. Hosier Revocable Trust,
has sole and dispositive power over the Ordinary Shares held by the Gerald D. Hosier Revocable Trust.
|
|
(2)
|
Based
on a total of 20,000,000 Ordinary Shares issued and outstanding as of August 12, 2021 as reported by the Issuer in its Quarterly Report
on Form 10-Q for the quarter ended June 30, 2021, filed by the Issuer with the SEC on August 12, 2021.
|
SCHEDULE
13G
This
Schedule 13G is filed jointly on behalf of the Gerald D. Hosier Revocable Trust, a trust formed in the State of Nevada (the “Trust”)
and Gerald D. Hosier, the sole trustee of the Trust (together with the Trust, the “Reporting Persons”).
Item
1(a).
|
Name
of Issuer
|
|
|
|
Orion
Biotech Opportunities Corp. (“Issuer”)
|
|
|
Item
1(b).
|
Address
of the Issuer’s Principal Executive Offices
|
|
|
|
645
Fifth Avenue
21st
Floor
New
York, New York 10022
|
Item
2(a).
|
Names
of Persons Filing
|
|
|
|
This
Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):
|
|
(i)
|
Gerald
D. Hosier Revocable Trust
|
|
(ii)
|
Gerald
D. Hosier
|
|
|
|
Item
2(b).
|
Address
of the Principal Business Office, or if none, Residence:
|
|
|
|
2020
Red Mountain Rd.
Aspen,
Colorado 81611
|
|
|
Item
2(c).
|
Citizenship
|
|
|
|
(i)
|
Gerald
D. Hosier Revocable Trust, a trust formed in the State of Nevada.
|
|
(ii)
|
Gerald
D. Hosier is a citizen of the United States.
|
|
|
|
Item
2(d).
|
Title
of Class of Securities
|
|
|
|
Class
A Ordinary Shares, $0.0001 par value (the “Ordinary Shares”)
|
|
|
Item
2(e).
|
CUSIP
Number
|
|
|
|
G6780C125
|
|
|
Item
3.
|
If
this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
|
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
|
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
|
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
|
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
(e)
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
(g)
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
(h)
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
(i)
A church plan that is excluded from the definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J),
please specify the institution: ________________;
|
|
(k)
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
|
|
|
Not
Applicable
|
Item
4.
|
Ownership
|
|
|
|
The
responses to Items 5-11 of the cover pages of this Schedule 13G are incorporated herein by
reference.
(a)
Amount beneficially owned: 1,500,000 Ordinary Shares
(b)
Percent of class: 7.5%
(c)
Number of shares to which the person has:
(i)
Sole power to vote or to direct the vote: 1,500,000 Ordinary Shares
(ii)
Shared power to vote or to direct the vote:
(iii)
Sole power to dispose or direct the disposition: 1,500,000 Ordinary Shares
(iv)
Shared power to dispose or to direct the disposition:
|
|
|
Item
5.
|
Ownership
of Five Percent or Less of a Class
|
|
|
|
If
this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial
owner of more than five percent of the class of securities, check the following ☐.
|
|
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another Person
|
|
|
|
Not
Applicable
|
|
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
|
|
|
|
Not
Applicable
|
|
|
Item
8.
|
Identification
and Classification of Members of the Group
|
|
|
|
Not
Applicable
|
|
|
Item
9.
|
Notice
of Dissolution of Group
|
|
|
|
Not
Applicable
|
|
|
Item
10.
|
Certification
|
|
|
|
By
signing below the undersigned certifies that, to the best of its or his knowledge and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other
than activities solely in connection with a nomination under § 240.14a-11.
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
Date:
October 15, 2021
|
Gerald
D. Hosier Revocable Trust
|
|
|
|
|
By:
|
/s/
Gerald D. Hosier
|
|
|
Name:
|
Gerald D. Hosier
|
|
|
Title:
|
Trustee of Gerald D. Hosier Revocable Trust
|
|
|
|
Date:
October 15, 2021
|
By:
|
/s/
Gerald D. Hosier
|
|
|
Gerald
D. Hosier
|
6
Orion Biotech Opportunit... (NASDAQ:ORIA)
Historical Stock Chart
From Apr 2024 to May 2024
Orion Biotech Opportunit... (NASDAQ:ORIA)
Historical Stock Chart
From May 2023 to May 2024